| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | A04AD13 |
| UNII: | 3B03KPM27L |
| InChI Key | XGGTZCKQRWXCHW-WMTVXVAQSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C30H35F7N4O2 |
| Molecular Weight | 616.62 |
| AlogP | 6.65 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 47.1 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 43.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | 9720-9860 | - | 4930 | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Neurokinin receptor
|
- | - | - | 0-0 | - | |
|
Membrane receptor
|
- | - | - | 0-0 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Postoperative Nausea and Vomiting | 3 | D020250 | ClinicalTrials |
| Nausea | 3 | D009325 | ClinicalTrials |
| Vomiting | 3 | D014839 | ClinicalTrials |
| Postoperative Nausea and Vomiting | 3 | D020250 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Sleep Initiation and Maintenance Disorders | 2 | D007319 | ClinicalTrials |
| Urinary Bladder, Overactive | 2 | D053201 | ClinicalTrials |
| Dyspepsia | 2 | D004415 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 414910-27-3 |
| ChEBI | 135967 |
| ChEMBL | CHEMBL1672054 |
| DrugBank | DB06634 |
| DrugCentral | 4401 |
| FDA SRS | 3B03KPM27L |
| Guide to Pharmacology | 5758 |
| PharmGKB | PA166129533 |
| PubChem | 9917021 |
| SureChEMBL | SCHEMBL425342 |
| ZINC | ZINC000042856596 |